MCRB vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

MCRB

43.9
AI Score
VS
CLYM Wins

CLYM

51.1
AI Score

Investment Advisor Scores

MCRB

44score
Recommendation
HOLD

CLYM

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MCRB CLYM Winner
Net Income -250.16M -13.72M CLYM
Operating Income -179.91M -15.21M CLYM
ROE -2319.9% -9.3% CLYM
ROA -71.7% -9.0% CLYM
Total Assets 348.78M 152.37M MCRB
Cash 163.03M 8.36M MCRB
Current Ratio 2.28 27.86 CLYM
Free Cash Flow -238.64M -14.56M CLYM

Relative Price Performance (Last 90 Days)

MCRB 1M: -30.5% · 3M: -30.3% CLYM 1M: -4.8% · 3M: +30.3%

Current Technical Phase

MCRB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.7%), weak momentum, RSI 45

RSI (14): 44.9 · Price: $5.36

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.6% over 20 days), RSI 52

RSI (14): 51.8 · Price: $12.63

Fundamentals Snapshot

Metric MCRB CLYM
Market Cap
Forward P/E -0.8 -10.4
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% 0.0%
Gross Margin -45.6%
Operating Margin -58.4% 0.0%
EPS -5.20 -0.77
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.